Business · 06/12/2017Updated: 10/17/2026 · 1 min read
FDA Announces Guidance on Reducing Trypanosoma cruzi Infection Risk in Blood and Blood Components
Summary
The FDA has released a new guidance document outlining recommendations for blood collection establishments to minimize the risk of Trypanosoma cruzi infection transmission in blood and blood components, superseding previous guidance from 2010